Abstract
We analyzed the clinical efficacy and safety of chemotherapy using S-1 plus weekly CDDP( w-CS therapy) for unresectable gastric cancer. Twenty one patients were treated with this treatment. S-1 80 mg/m2/day was administered for 2 weeks followed by a 1-week rest. CDDP 20 mg/m2 was injected intravenously on day 1 and 8. The overall response rate was 52. 3%. The disease control rate was 85.7%. Grade 3 or 4 major toxicity comprised neutropenia (14.2%), thrombocytopenia (4.7%) and plasma creatinine elevation (4.7%). w-CS therapy is satisfied resulting with efficacy and safety. Thus, future clinical trials and accumulation of futher cases are warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 2351-2353 |
| Number of pages | 3 |
| Journal | Gan to kagaku ryoho. Cancer & chemotherapy |
| Volume | 38 |
| Issue number | 12 |
| Publication status | Published - 2011 Nov |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Kemmochi, T., Egawa, T., Mihara, Y., Irino, T., Ito, Y., Nagashima, A., Makino, H., & Yamamuro, W. (2011). [Treatment of S-1 plus weekly CDDP for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 38(12), 2351-2353.